These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10933647)

  • 21. Effect of sparfloxacin on Staphylococcus aureus adhesiveness and phagocytosis.
    Desnottes JF; Diallo N
    J Antimicrob Chemother; 1994 Apr; 33(4):737-46. PubMed ID: 8056692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pefloxacin on phagocytosis function of rat macrophages and polymorphonuclear leucocytes.
    Desnottes JF; Jacotot F; Bruel J; Bassoullet MT; Niel G
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():53-7. PubMed ID: 3458698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of anaerobes to quinolones in the United States.
    Hecht DW; Wexler HM
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S2-8. PubMed ID: 8953099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].
    Tani M; Maebashi K; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):882-5. PubMed ID: 12621742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pefloxacin activity against recent clinical isolates.
    Lembo M; Covelli B; Nani E; Lavitola A
    J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
    Miguères ML; Ronco E; Guenounou M
    Pathol Biol (Paris); 1990 May; 38(5):385-9. PubMed ID: 2195447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.
    Moreau NJ; Houot S; Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1996 Dec; 38(6):1079-83. PubMed ID: 9023657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp.
    Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1992 Apr; 29(4):466-8. PubMed ID: 1318878
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of lomefloxacin on phagocytosis and killing activity of macrophages and neutrophils.
    Mato R; Corrales I; Prieto J
    J Antimicrob Chemother; 1992 Oct; 30(4):558-9. PubMed ID: 1337071
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
    Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
    Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of intramacrophagic penetration and action on phagocytosis of a macrolide (spiramycin) and a fluoroquinolone (pefloxacin)].
    Desnottes JF; Diallo N
    Pathol Biol (Paris); 1990 Apr; 38(4):281-5. PubMed ID: 2377388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of furazolidone pretreatment of Salmonella enteritidis PT4 at sub- and suprainhibitory concentrations on phagocytosis and intracellular survival in chicken macrophages.
    Chadfield MS; Hinton MH
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):81-97. PubMed ID: 15182998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of lomefloxacin on the functional activity of the phagocytic system].
    Mozhokina GN; Gracheva MP; Sokolova GB
    Antibiot Khimioter; 1996 Mar; 41(3):25-8. PubMed ID: 8967798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro antimicrobial activity of the new fluoroquinolone, grepafloxacin, against pathogenic Nocardia spp.
    Yazawa K; Mikami Y
    J Antimicrob Chemother; 1995 Apr; 35(4):541-4. PubMed ID: 7628988
    [No Abstract]   [Full Text] [Related]  

  • 40. [Yersinia pseudotuberculosis sensitivity to fluoroquinolones and the efficacy of pefloxacin in experimental pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):49-52. PubMed ID: 9432847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.